Therapeutic gold. Is it due for a come-back?

Inflammopharmacology

Volumn 16, Issue 3, 2008, Pages 107-109

  Whitehouse, M W ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AURANOFIN; AUROTHIOGLUCOSE; AUROTHIOMALATE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GOLD; GOLD COMPLEX; INTERLEUKIN 1 ANTIBODY; MERCURY CHLORIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

DRUG INDICATION; DRUG MECHANISM; HISTORY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; UNSPECIFIED SIDE EFFECT;

GOLD; HUMANS; RHEUMATIC DISEASES;

EID: 46449129601     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-007-0022-9     Document Type: Review

References (36)

1. Bitter, T. (1984). Combined disease-modifying chemotherapy for intractable rheumatoid arthritis. Clin. Rheum. Dis. 10, 417-28.
2. Brown, C., Bushell, G., Whitehouse, M., Agrawal, D. S., Tupe, S. G., Paknikar, K. M. et al. (2007). Nanogold pharmaceutics. Gold Bulletin, 40, 245-250.
3. Brown, D. H., Smith, W. E. (1980). The chemistry of gold drugs used in the treatment of rheumatoid arthritis. Quart. Rev. Chem. Soc. 9, 217-40.
4. Burnett, J. C. (1879) Gold as a remedy in disease. Reprinted Jain Publ. Ho. New Delhi (various dates).
5. Carey, J. B., Carey, M. A., Allshire, A., van Pelt, F. W. (2005). Tipping the balance towards tolerance: the basis for therapeutic immunomodulation by gold. Autoimmunity 38, 393-7.
6. Eisler, R. (2003). Chrysotherapy: a synoptic review. Inflamm. Res. 52, 487-501.
7. Epstein, W. V. (1989). Parenteral gold therapy for rheumatoid arthritis: a treatment whose time has gone. J. Rheumatol. 16, 1291-4.
8. Forestier, J. (1935). Rheumatoid arthritis and its treatment by gold salts. J. Lab. Clin. Med. 20, 827-40.
9. Graham, G. G., Ziegler, J. B., et al. (1993). Medicinal chemistry of gold. Agents & Actions, Suppl. 44, 209-17.
10. Graham, G. G., Whitehouse, M. W., Bushell, G. R. (2008). Aurocyanide, diocyano-aurate (I), a pharmacologically active metabolite of medicinal gold complexes. Inflammopharmacol. (this Symposium)
11. Haynes, D. R. and Whitehouse, M. W. (1989). Gold(I) thiolates: slow acting anti-arthritic drugs, in New Developments in antirtheumatic therapy. (Rainsford, K. D., Velo, G. P. (eds.) Kluwer Academic, Dordrecht, pp. 207-33.
12. Kataoka, K., Handa, H., Nishizowa, M. (2001). Induction of cellular antioxidative stress genes. J. Biol. Chem. 276, 34074-81.
13. Kean, W. F., Forester, F., Kassam, Y., Buchanan, W. W., Rooney, P. J. (1985). The history of gold therapy in rheumatoid disease. Sem. Arthr. Rheum. 14, 180-6.
14. Kean, W. F., Lock, C. J. L., Howard-Lock, H. (1991). Gold complexes research in medical science. Difficulties with experimental design. Inflammopharmacol. 1, 103-14.
15. Kean, W. F., Rainsford, K. D. (1996). In Memoriam. Colin James Lyne Lock. Inflammopharmacol. 4, 207.
16. Kobayashi, M., Takeno, M., Saito, T., Takeda, Y., Kirino, Y., Noyori, K. et al. (2006). Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum. 54, 1132-42.
17. Laist, J. W. (1954). Copper, silver and gold In Comprehensive Inorganic Chemistry (eds. Sneed, M. C., Maynard, J. L., Brasteed, R. C.) New York, van Nostrand Co. Vol. II, pp. 195-206.
18. Lehtinen, K., Isomaki, H. (1991). Intramuscular gold therapy is associated with long survival in patients with rheumatoid arthritis. J. Rheumatol. 18, 524-9.
19. Lewis, A. J. and Walz, D. T. (1982). Immunopharmacology of gold. Prog. Med. Chem. 19, 1-57.
20. Leibfarth, J. H., Persellin, R. H. (1981). Mechanisms of action of gold. A review. Agents Actions 11, 458-72.
21. Mallya, S. K., van Wart, H. E. (1989). Mechanism of inhibition of human neutrophil collagenase by gold(I) chrysotherapeutic compounds. J. Biol. Chem. 264, 1594-601.
22. Merchant, B. (1998). Gold, the Noble metal and the paradoxes of its toxicology. Biologicals 26, 49-59.
23. Messori, L., Marcon, G. (2004). Gold complexes in the treatment of rheumatoid arthritis In Metal Ions In Biological Systems (ed Sigel, H. and Sigel, A.) Vol. 41, 279-304.
24. Olynik, G. P., Guthrie, B. J. (1984). Canine pemphigus vulgaris treated with gold salt (sic) therapy. Can. Vet. J. 25, 168-70.
25. Parish, R. V., Cottrill, S. M. (1987). Medicinal gold compounds. Gold Bulletin 20, 3-12.
26. Penneys, N. S., Ziboh, V., Gottlieb, N. L., Katz, S. (1974). Inhibition of prostaglandin synthesis and human epidermal enzymes by aurothiomalate in vitro: possible actions of gold in pemphigus. J. Invest. Dermatol. 63, 356-61.
27. Rainsford, K. D. (2006). Professor William Watson Buchanan. Inflammopharmacol. 14, 103-119.
28. Rau, R. (2005). Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents. Clin. Rheumatol. 24, 189-202.
29. Roche, P. A. (2006). Gold-plating MHC class II molecules. Nature Chem. Biol. 2, 178-9.
30. Shaw, C. F. (1999). Gold-based therapeutic agents. Chem. Rev. 99, 2589-600.
31. Spurstowe, W. (1659). From 'The wells of salvation opened', Reproduced In Day by Day with the English Puritans (ed. Pederson, R. J.). Peabody Mass. Hendrickson Publ. 2004, p. 120.
32. Srinivasa, N. R., Miller, B. L., Paulus, H. E. (1979). Long-term chrysotherapy in rheumatoid arthritis. Arthritis Rheum. 22, 105-10.
33. Taha, A. S. and Sturrock, I. D. (1993). The gold-plated stomach? Ann. Rheum. Dis. 52, 89-90.
34. nd Edition, 66 pp.
35. Vuolteenaho, K., Kujala, P., Moilanen, T., Moilanen, E. (2000). Aurothiomalate and hydroxychloroquine inhibit nitric oxide production in chondrocytes and in human osteoarthritic cartilage. Scand. J. Rheumatol. 34, 475-9.
36. Wigley, R. A., Brooks, R. R. (1992). Gold and silver in medicine In Noble Metals and Biological Systems (ed. Brooks, R. R.) Boca Raton, CRC Press. p. 277-301.